CD20: a regulator of cell-cycle progression of B lymphocytes
- 1 September 1994
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 15 (9), 450-454
- https://doi.org/10.1016/0167-5699(94)90276-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.The Journal of cell biology, 1993
- Cell Cycle Dependence of Chloride Permeability in Normal and Cystic Fibrosis LymphocytesScience, 1990
- Phosphorylation of the CD20 Phosphoprotein in Resting B LymphocytesPublished by Elsevier ,1989
- Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytesMolecular Immunology, 1988
- Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (B1, Bp35), a type III integral membrane protein.The Journal of Experimental Medicine, 1988
- Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains.The EMBO Journal, 1988
- Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytesEuropean Journal of Immunology, 1986
- B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.Journal of Clinical Investigation, 1984
- Further Biochemical Studies of the Human B-Cell Differentiation Antigens B1 and B2Hybridoma, 1983